Prostate Cancer
Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention.
January 9, 2023
Technical note: Investigating the suitability of existing facilities for a new Lu-177 prostate-specific membrane antigen therapy program.
January 6, 2023
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
January 6, 2023
Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.
January 6, 2023
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
January 6, 2023
Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis
January 5, 2023
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial.
January 5, 2023
A Low PSA Predicts a Worse Outcome in High but Not in Low/Intermediate Grade Prostate Cancer
January 4, 2023
Five-year patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer.
January 4, 2023
Radiorecurrent prostate cancer: advantages and disadvantages of salvage radical prostatectomy.
January 4, 2023